Your browser is no longer supported. Please, upgrade your browser.
Aptorum Group Limited
Index- P/E14.56 EPS (ttm)0.17 Insider Own26.40% Shs Outstand32.31M Perf Week-5.68%
Market Cap85.11M Forward P/E- EPS next Y-1.13 Insider Trans0.00% Shs Float8.52M Perf Month-23.85%
Income6.30M PEG- EPS next Q- Inst Own1.50% Short Float2.22% Perf Quarter-30.64%
Sales0.90M P/S94.56 EPS this Y131.10% Inst Trans- Short Ratio0.61 Perf Half Y18.57%
Book/sh1.29 P/B1.93 EPS next Y1.60% ROA21.70% Target Price- Perf Year-22.43%
Cash/sh0.93 P/C2.67 EPS next 5Y- ROE24.50% 52W Range1.16 - 14.23 Perf YTD0.81%
Dividend- P/FCF- EPS past 5Y- ROI-46.00% 52W High-82.50% Beta-
Dividend %- Quick Ratio8.70 Sales past 5Y- Gross Margin-11.40% 52W Low114.66% ATR0.24
Employees24 Current Ratio8.70 Sales Q/Q50.00% Oper. Margin- RSI (14)38.23 Volatility8.68% 10.16%
OptionableNo Debt/Eq0.06 EPS Q/Q171.10% Profit Margin- Rel Volume0.36 Prev Close2.50
ShortableYes LT Debt/Eq0.05 Earnings- Payout0.00% Avg Volume308.36K Price2.49
Recom2.00 SMA20-4.91% SMA50-14.19% SMA200-10.46% Volume110,596 Change-0.40%
May-06-21 07:00AM  
Apr-23-21 11:35AM  
Apr-22-21 09:04AM  
Apr-19-21 07:00AM  
Mar-31-21 07:00AM  
Jan-20-21 07:32AM  
Jan-16-21 01:23AM  
Dec-21-20 06:00AM  
Dec-10-20 08:00AM  
Oct-16-20 08:00AM  
Oct-02-20 04:05PM  
Sep-29-20 09:00PM  
Sep-08-20 03:00AM  
Sep-02-20 08:00AM  
Sep-01-20 02:00AM  
Aug-31-20 06:05PM  
Aug-26-20 03:00AM  
Aug-20-20 02:00AM  
Aug-05-20 11:04AM  
Jul-24-20 02:00AM  
Jul-17-20 06:20AM  
Jul-03-20 12:56PM  
Jun-25-20 11:25AM  
Jun-15-20 08:00AM  
Apr-29-20 08:00AM  
Apr-15-20 08:00AM  
Mar-30-20 08:00AM  
Mar-24-20 04:00PM  
Feb-28-20 01:00PM  
Feb-26-20 09:15AM  
Feb-24-20 06:00AM  
Feb-10-20 08:00AM  
Jan-03-20 05:38AM  
Nov-15-19 08:00AM  
Sep-19-19 08:10AM  
Sep-09-19 06:34AM  
Jul-11-19 08:00AM  
Jul-08-19 08:00AM  
Jun-26-19 11:05AM  
May-22-19 08:00AM  
May-15-19 09:00PM  
May-07-19 07:19AM  
May-06-19 08:00AM  
Apr-30-19 10:42AM  
Apr-24-19 08:00AM  
Apr-15-19 09:55AM  
Apr-01-19 09:30AM  
Mar-08-19 02:49PM  
Mar-04-19 11:26AM  
Feb-25-19 05:28AM  
Dec-07-18 02:07AM  
Feb-28-18 05:20AM  
Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly infectious diseases and cancers. Its pipeline through the establishment of drug discovery platforms enable the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases. The company is also pursuing therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, women's health, and other disease areas. It also has projects focused on surgical robotics and natural supplement for women undergoing menopause and experiencing related symptoms. Aptorum Group Limited was incorporated in 2010 and is headquartered in London, the United Kingdom.